甲状腺髓样癌预后相关因素研究进展

王 艺儒1, 张 聪2, 姜战 武*3
1、承德医学院研究生学院;保定市第一中心医院普通外二科
2、承德医学院研究生学院;保定市第一中心医院影像科
3、保定市第一中心医院普通外二科

摘要


甲状腺髓样癌（Medullary Thyroid Carcinoma，MTC）是一种起源于甲状腺滤泡旁细胞的神经内分泌恶性肿瘤，约占甲状腺癌的2%-3%。由于部分MTC患者在疾病早期便可出现局部及远处转移，所以研究预后相关因素，早期评估，早期干预，显得尤为重要。本文就个人属性、病理因素、局部淋巴结转移情况、超声特征等方面进行综述，希望可以给临床MTC患者的诊治提供一定的参考。

关键词


甲状腺髓样癌；预后因素；降钙素；淋巴结转移比值

全文:

PDF


参考


[1]Randle R W, Balentine C J, Leverson G E, et al. Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years[J]. Surgery, 2017, 161(1): 137-146.

[2]Zhang K, Wang X, Wei T, et al. Well-defined survival outcome disparity across age cutoffs at 45 and 60 for medullary thyroid carcinoma: a long-term retrospective cohort study of 3601 patients[J]. Frontiers in Endocrinology, 2024, 15: e1393904.

[3]Kotwal A, Erickson D, Geske J R, et al. Predicting outcomes in sporadic and hereditary medullary thyroid carcinoma over two decades[J]. Thyroid, 2021, 31(4): 616-626.

[4]Liu B, Peng Y, Su Y, et al. Treatment and management of medullary thyroid microcarcinoma: a 10-year retrospective study from a single center[J]. Endocrine, 2024, 86(3): 1081-1089.

[5]王士琪，储红映，赵再礼，等.123例甲状腺髓样癌患者的预后分析[J].肿瘤预防与治疗，2019，32（12）：1099-1105.

[6]Hamdy O, Awny S, Metwally I. Medullary thyroid cancer: epidemiological pattern and factors contributing to recurrence and metastasis[J]. Annals of the Royal College of Surgeons of England, 2020, 102(7): 499-503.

[7]Hao W, Zhao J, Guo F, 等. Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer[J]. PeerJ, 2023, 11: e15025.

[8]Guo F L, Li L J, Ruan X H, et al. [risk factors of recurrence or metastasis in patients with medullary thyroid carcinoma][J]. Zhonghua Yi Xue Za Zhi, 2022, 102(48): 3849-3855.

[9]Zhao J, Zheng X, Gao M, et al. Ultrasound features of medullary thyroid cancer as predictors of biological behavior[J]. Cancer Imaging, 2021, 21(1): 33.

[10]Hou Y, Yang Y, Chen G, et al. The impact of preoperative calcitonin screening on the prognosis of patients with medullary thyroid cancer: a retrospective multicenter cohort study[J]. Endocrine, 2024, 85(2): 827-836.

[11]Guo F, Fu G, Li F, et al. Time kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma[J]. World Journal of Surgical Oncology, 2024, 22(1): 121.

[12]Kim J, Park J, Park H, et al. Metastatic lymph node ratio for predicting recurrence in medullary thyroid cancer[J]. Cancers, 2021, 13(22): 5842.

[13]Turkdogan S, Forest V-I, Hier M P, et al. Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer[J]. Journal of Otolaryngology - Head & Neck Surgery, 2018, 47(1): 55.


Refbacks

  • 当前没有refback。